<DOC>
	<DOCNO>NCT00646555</DOCNO>
	<brief_summary>This study , conduct NCI George Washington University Medical Center ( GWUMC ) , examine breast tissue patient inflammatory breast cancer ( IBC ) tumor marker factor associate angiogenesis . Angiogenesis formation new blood vessel essential tumor growth spread . IBC extremely rare , aggressive form breast cancer disproportionately affect young woman . The risk factor IBC , cause , develop unknown , disease appear involve high degree angiogenesis . Tissue specimens study obtain GWUMC 's Inflammatory Breast Cancer Registry Biospecimen Repository . The registry establish develop national registry patient IBC include standardized clinical , epidemiological , pathological information , along disease recurrence survival data . For study , tissue specimen repository test biological marker angiogenesis parameter help classification tumor . Biological marker ( estrogen receptor , progesterone receptor , p53 gene , others ) angiogenesis parameter ( various protein involve vessel formation ) examine determine prevalence tissue specimens relationship patient survival . When possible , finding compare non-IBC tissue sample .</brief_summary>
	<brief_title>Inflammatory Breast Cancer , Tumor Markers , Factors Associated With Angiogenesis</brief_title>
	<detailed_description>Inflammatory breast carcinoma ( IBC ) extremely rare , aggressive form breast cancer disproportionately affect young woman . The risk factor pathogenesis tumor unknown unclear whether tumor show various clinical , pathological molecular feature behave differently . IBC appear highly angiogenic tumor . In study , tumor marker parameter angiogenesis investigate IBC . The Inflammatory Breast Cancer Registry Biospecimen Repository project fund grant Department Defense Paul H. Levine GWUMC . The purpose registry develop national registry patient IBC contain standardized clinical , epidemiological , pathological information , along recurrence survival data . The goal obtain specimen approximately 150 patient IBC . The data registry repository make available researcher aid development clinicopathological diagnosis IBC . Investigators GWUMC consent recruit patient collect clinical data . Subjects recruit , evaluate , monitor NCI . The GWUMC IRB oversee human subject protection issue . All sample obtain GWUMC blind coded NCI investigator . In addition sample George Washington University , obtain 150 control sample National Cancer Institute Cooperative Breast Cancer Tissue Resource . These sample available protocol first submit . In collaboration George Washington University Medical Center ( GWUMC ) , plan test tissue specimen collect IBC registry biospecimen repository . We obtain frozen tissue ( tissue and/or normal ) paraffin-embedded tissue block case . Genetic testing perform sample . One pathologist review case grade lymphovascular invasion ( LVI ) base H &amp; E staining . Specimens test biological marker associate IBC help classification tumor . These include ER , E-cadherin , podoplanin , ReIB , RhoC vasodilator-stimulated phosphoprotein ( VASP ) . Angiogenesis parameter also evaluate . These include hypoxia-inducible factor 1 alpha ( HIF-1 alpha ) , vascular endothelial growth factor D ( VEGF-D ) protein expression , VEGF-C protein expression , VEGF-receptor 2 ( VEGFR-2 , Kdr ) VEGF-receptor 3 ( VEGFR-3 , flt-4 ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Inflammatory Breast Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients inflammatory breast cancer . Age great 18 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 10, 2012</verification_date>
	<keyword>Tissue Samples</keyword>
	<keyword>VEGF Receptors</keyword>
	<keyword>VEGF</keyword>
	<keyword>Microvessel Density</keyword>
	<keyword>Hypoxia Inducible Factor</keyword>
	<keyword>Inflammatory Breast Cancer</keyword>
	<keyword>IBC</keyword>
</DOC>